LianBio is a biotechnology company with headquarters in both New Jersey and Shanghai. The IPO for its U.S.-listed shares priced at $16 each. ( read original story ...)
China-SCO Local Economic Cooperation Demonstration Zone in Qingdao ushers in the first overseas investment fund
The China-SCO local economic cooperation demonstration zone will run the fund in collaboration with Sino-Russian Energy Investment Private Equity Fund Management (Qingdao) Co Ltd. ( read original story ...)
I-Mab Strengthens Senior Executive Team with New Chief Financial Officer and Chief Strategy Officer Appointments
I-Mab (the “Company”) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced the appointment of ... ( read original story ...)
ACM Research’s Operating Subsidiary ACM Research (Shanghai) Provides Updated IPO Prospectus and IPO Timetable
FREMONT, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer cleaning technologies for advanced semiconductor devices, today is providing an update on the ... ( read original story ...)
Zhangmen Education Inc. Reports Second Quarter 2021 Unaudited Financial Results
Zhangmen Education Inc. ("Zhangmen" or the "Company") (NYSE: ZME), a leading online education company in China, today announced its unaudited financial results for the second quarter ended June 30, ... ( read original story ...)
China-Focused Biotech LianBio Raises $325 Million in U.S. IPO
Biotechnology firm LianBio raised $325 million in an initial public offering, according to a statement, potentially opening a narrow path for U.S. listings by companies operating primarily in ... ( read original story ...)
MARKETS: Indices eye firm start; Policybazaar, 2 other IPOs to open today
While Sigachi and SJS Enterprises' IPOs will open today, Nykaa's issue will close and Fino Payments Bank's PO will enter its second day today ... ( read original story ...)